Glassman Wealth Services Insmed Inc Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$20.42 - $28.13 $163 - $225	-8 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $1,812 - $2,341	-70 Reduced 89.74%	8 $0
Q3 2021 Nov 10, 2021	BUY	$22.46 - $29.47 $1,751 - $2,298	78 New	78 $2,000
Q2 2019 Aug 08, 2019	SELL	$23.0 - $32.19 $207 - $289	-9 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$13.91 - $31.15 $125 - $280	9 New	9 $0

480

182M

2.27M

3.32M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $11B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.